Listar por autor "Herrera-Imbroda, Jesús"
Mostrando ítems 1-4 de 4
-
Aciletanolamidas como biomarcadores en trastorno por uso de sustancias: influencia de la medicación psicotrópica.
(UMA Editorial, 2024)La presente tesis doctoral se presenta por compendio de publicaciones y comprende tres trabajos realizados por el doctorando durante su Programa de Doctorado. El primero de ellos se trata de una revisión narrativa sobre ... -
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder.
Herrera-Imbroda, Jesús; Flores-López, María; Requena-Ocaña, Nerea; Araos Gómez, Pedro Fernando; Ropero, Jessica; García-Marchena, Nuria; Bordallo Aragón, Antonio; Suárez-Pérez, Juan
; Pavón-Morón, Francisco Javier; Serrano, Antonia; Mayoral Cleries, Fermín; Rodriguez-de-Fonseca, Fernando[et al.] (MDPI, 2023-05-27)
Plasma acylethanolamides (NAEs), including the endocannabinoid anandamide (AEA), have been proposed as circulating biomarkers of substance use disorders. However, the concentration of these lipid transmitters might be ... -
Benzotriazole-based multidonor-acceptor systems as attractive two-photon absorption dye platforms
Benítez-Martín, Carlos; Donoso, Beatriz; Torres-Moya, Ivan; Herrera-Imbroda, Jesús; Díaz-Ortiz, Ángel; Nájera-Albendín, Francisco; Prieto, Pilar; Pérez-de-Inestrosa-Villatoro, Ezequiel[et al.] (Elsevier, 2022-02-03)
Pyrazine-decorated benzotriazole cores allow the orthogonal combination of two dipolar systems within a single molecule. A series of this type of derivatives was synthesized and their photophysical features were studied. ... -
Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review
Ruiz-Sastre, Paloma; Gómez-Sánchez-Lafuente, Carlos; Martín-Martín, Jaime; Herrera-Imbroda, Jesús; Mayoral Cleries, Fermín; Santos-Amaya, Ignacio Miguel; Rodriguez-de-Fonseca, Fernando; Guzmán-Parra, José; Rivera, Patricia; Suárez-Pérez, Juan[et al.] (Elsevier, 2024-06-13)
Background: The various pharmacological interventions, ranging from mood stabilizers and antipsychotics to antidepressants, reflect the diff/iculty of treating depressive/manic symptomatology of bipolar disorder (BD). Among ...